173 related articles for article (PubMed ID: 35484681)
1. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
Smeland K; Holte H; Fagerli UM; Bersvendsen H; Hjermstad MJ; Loge JH; Murbrach K; Linnsund MD; Fluge O; Stenehjem JS; Lund MB; Kvaloy S; Kiserud CE
Haematologica; 2022 Nov; 107(11):2698-2707. PubMed ID: 35484681
[TBL] [Abstract][Full Text] [Related]
2. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE
BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789
[TBL] [Abstract][Full Text] [Related]
3. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.
Kiserud CE; Fagerli UM; Smeland KB; Fluge Ø; Bersvendsen H; Kvaløy S; Holte H; Dahl AA
Acta Oncol; 2016 May; 55(5):547-53. PubMed ID: 27123741
[TBL] [Abstract][Full Text] [Related]
4. Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
Simensen VC; Smeland KB; Kiserud CE; Dahl AA; Bersvendsen HS; Fluge Ø; Fagerli UM; Fosså A
Acta Oncol; 2019 Sep; 58(9):1315-1322. PubMed ID: 31286808
[No Abstract] [Full Text] [Related]
5. Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma.
Gulbrandsen MS; Nøding AS; Smeland KB; Eikeland SA; Kiserud CE; Hjermstad MJ; Fosså A
Leuk Lymphoma; 2023 Jun; 64(6):1139-1150. PubMed ID: 37144290
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
Bersvendsen HS; Haugnes HS; Fagerli UM; Fluge Ø; Holte H; Smeland KB; Wilsgaard T; Kiserud CE
Acta Oncol; 2019 May; 58(5):690-699. PubMed ID: 30696346
[No Abstract] [Full Text] [Related]
7. Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
Baech J; Husby S; Trab T; Kragholm K; Brown P; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Severinsen MT; Grønbaek K; Larsen TS; Wästerlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
Br J Haematol; 2024 Mar; 204(3):967-975. PubMed ID: 38155503
[TBL] [Abstract][Full Text] [Related]
8. Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy SO; Wethal T; Kiserud CE; Samersaw-Lund MB
Acta Oncol; 2018 Jun; 57(6):773-781. PubMed ID: 29171324
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.
Seland M; Smeland KB; Bjøro T; Falk RS; Fosså SD; Gjesdal CG; Godang K; Holte H; Svartberg J; Syversen U; Bollerslev J; Kiserud CE
Acta Oncol; 2017 Apr; 56(4):590-598. PubMed ID: 28077016
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.
Dahi PB; Tamari R; Devlin SM; Maloy M; Bhatt V; Scordo M; Goldberg J; Zelenetz AD; Hamlin PA; Matasar MJ; Maragulia J; Giralt SA; Perales MA; Moskowitz CH; Sauter CS
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2004-9. PubMed ID: 25175794
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma.
Kerhuel L; Amorim S; Azoulay E; Thiéblemont C; Canet E
Leuk Lymphoma; 2015; 56(11):3090-5. PubMed ID: 25813206
[TBL] [Abstract][Full Text] [Related]
13. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.
Lahoud OB; Sauter CS; Hamlin PA; Dahi PB
Curr Oncol Rep; 2015 Sep; 17(9):42. PubMed ID: 26201264
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Gerrie AS; Power MM; Shepherd JD; Savage KJ; Sehn LH; Connors JM
Ann Oncol; 2014 Nov; 25(11):2218-2223. PubMed ID: 25149708
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study.
Hjermstad MJ; Evensen SA; Kvaløy SO; Fayers PM; Kaasa S
J Clin Oncol; 1999 Feb; 17(2):706-18. PubMed ID: 10080617
[TBL] [Abstract][Full Text] [Related]
16. Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma.
Dean HF; Cazaly A; Hurlock C; Borras J; Williams AP; Johnson PW; Davies AJ
Bone Marrow Transplant; 2012 Dec; 47(12):1545-51. PubMed ID: 22580768
[TBL] [Abstract][Full Text] [Related]
17. Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation.
Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy S; Thorsen L; Arbo I; Jones LW; Aakhus S; Lund MB; Kiserud CE
Br J Cancer; 2016 Jul; 115(2):178-87. PubMed ID: 27351215
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.
Kondo E; Ikeda T; Izutsu K; Chihara D; Shimizu-Koresawa R; Fujii N; Sakai T; Kondo T; Kubo K; Kato Y; Akasaka T; Fukuda T; Ichinohe T; Atsuta Y; Suzumiya J; Suzuki R;
Biol Blood Marrow Transplant; 2019 May; 25(5):899-905. PubMed ID: 30664936
[TBL] [Abstract][Full Text] [Related]
19. Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.
Joseph NS; Gupta VA; Wyman S; Graiser M; Kaufman JL; Almaula D; Andrews J; Hofmeister C; Dhodapkar M; Heffner LT; Lonial S; Nooka AK
Transplant Cell Ther; 2022 Feb; 28(2):75.e1-75.e7. PubMed ID: 34626863
[TBL] [Abstract][Full Text] [Related]
20. High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.
Schorb E; Fox CP; Fritsch K; Isbell L; Neubauer A; Tzalavras A; Witherall R; Choquet S; Kuittinen O; De-Silva D; Cwynarski K; Houillier C; Hoang-Xuan K; Touitou V; Cassoux N; Marolleau JP; Tamburini J; Houot R; Delwail V; Illerhaus G; Soussain C; Kasenda B
Bone Marrow Transplant; 2017 Aug; 52(8):1113-1119. PubMed ID: 28436974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
